₹393.95
+5.31% today
· 30d +10.2%
as of 2026-09-04
Price · Daily Candles
“SMS Pharma sees 28% profit surge as FIIs nibble, but MACD flashes bearish signal.”
SMS Pharma demonstrated a robust Q4 2025 with net profit up 28.67% YoY to ₹23 Cr and revenue rising 21.4% YoY to ₹210 Cr. Despite this operational strength and steady FCF growth predictions (0.631 rank), the stock's valuation appears stretched with a P/E of 37.48 and a weak technical outlook.
BULL CASE
+Q4 2025 net profit increased 28.67% YoY to ₹23 Cr, showcasing strong quarterly performance.
+Quarterly revenue grew 21.4% YoY to ₹210 Cr, driven by operational efficiency with OPM up 1.99% YoY.
+FIIs increased their stake by 0.27% QoQ to 0.31% in Q4 2026.
+Annual net profit for 2025 was up 38.74% YoY to ₹69 Cr, significantly outpacing revenue growth of 9.67%.
BEAR CASE
−The stock is trading with a P/E of 37.48, significantly higher than peer GLAXO (37.32) and PFIZER (29.39).
−Technical indicators are weak, with a 'strong bearish' MACD and a 'weak neutral' RSI(14) at 40.59.
−Despite positive profit growth, the company is currently free-cash-flow negative at -₹42 Cr.
−The stock price is 16.1% off its 52-week high of ₹447.8, with a 1-month return of -5.29%.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹207 Cr
+5.57% YoY
NET PROFIT
₹21 Cr
+2.04% YoY
OPM
20.46%
+0.13pp YoY
EPS
₹2.23
PE 37.48
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.9% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
SMS Pharma's TTM P/E of 37.48 positions it above peers like GSK (37.32) and Pfizer (29.39), but its ROCE of 13.0% lags significantly behind sector leaders such as GLAXO (60.28%) and SANOFICONR (84.87%).
PEERPEROCE %
SMSPHARMA37.4813.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
66
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
100
Valuation
FAIR
40
Growth
STRONG
75
Profitability
DECENT
68
Technicals
NEUTRAL
65
Risk
MODERATE
50
Key Stats
TTM PE
37.48
P/B
4.6
52W HIGH
₹447.8
OFF HIGH
-12.03%
DIV YIELD
0.09%
MKT CAP
₹3695 Cr
◉ Active Signals
MACDBullish4.0487
RSI(14)Bullish64.35
⧉ Strategy Fit 🔒